R&D Costs For Pharmaceutical Companies Do Not Explain Elevated US Drug Prices

Health Affairs

Archives

That pharmaceutical companies charge much more for their drugs in the United States than they do in other Western countries has contributed to public and political distrust of their pricing practices. When these higher US prices (which are sometimes cited Read More...

Read the complete post at http://healthaffairs.org/blog/2017/03/07/rd-costs-for-pharmaceutical-companies-do-not-explain-elevated-us-drug-prices/


Posted Mar 07 2017, 04:58 AM by Health Affairs BlogHealth Affairs Blog